These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 11483905)

  • 21. Trospium chloride for the treatment of overactive bladder with urge incontinence.
    Singh-Franco D; Machado C; Tuteja S; Zapantis A
    Clin Ther; 2005 May; 27(5):511-30. PubMed ID: 15978301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solifenacin plus tamsulosin combination treatment in men with lower urinary tract symptoms and bladder outlet obstruction: a randomized controlled trial.
    Kaplan SA; He W; Koltun WD; Cummings J; Schneider T; Fakhoury A
    Eur Urol; 2013 Jan; 63(1):158-65. PubMed ID: 22831853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative urodynamic evaluation may predict voiding dysfunction in women undergoing pubovaginal sling.
    Miller EA; Amundsen CL; Toh KL; Flynn BJ; Webster GD
    J Urol; 2003 Jun; 169(6):2234-7. PubMed ID: 12771757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in urethral function with bladder filling in the presence of urodynamic stress incontinence and detrusor overactivity.
    Chaliha C; Digesu GA; Hutchings A; Khullar V
    Am J Obstet Gynecol; 2005 Jan; 192(1):60-5. PubMed ID: 15672004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
    Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
    Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections.
    Gamé X; Castel-Lacanal E; Bentaleb Y; Thiry-Escudié I; De Boissezon X; Malavaud B; Marque P; Rischmann P
    Eur Urol; 2008 Mar; 53(3):613-8. PubMed ID: 17804150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of three methods to evaluate maximum bladder capacity: cystometry, uroflowmetry and a 24-h voiding diary in women with urinary incontinence.
    Ertberg P; Møller LA; Lose G
    Acta Obstet Gynecol Scand; 2003 Apr; 82(4):374-7. PubMed ID: 12716323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response to fesoterodine in patients with an overactive bladder and urgency urinary incontinence is independent of the urodynamic finding of detrusor overactivity.
    Nitti VW; Rovner ES; Bavendam T
    BJU Int; 2010 May; 105(9):1268-75. PubMed ID: 19889062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosing bladder outlet obstruction in women.
    Nitti VW; Tu LM; Gitlin J
    J Urol; 1999 May; 161(5):1535-40. PubMed ID: 10210391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urodynamic findings of the painful bladder syndrome/interstitial cystitis: a comparison with idiopathic overactive bladder.
    Kim SH; Kim TB; Kim SW; Oh SJ
    J Urol; 2009 Jun; 181(6):2550-4. PubMed ID: 19375103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urodynamic prolapse reduction alters urethral pressure but not filling or pressure flow parameters.
    Mueller ER; Kenton K; Mahajan S; FitzGerald MP; Brubaker L
    J Urol; 2007 Feb; 177(2):600-3. PubMed ID: 17222641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary nocturnal enuresis persistent to adulthood, functional evaluation.
    Wadie BS
    Neurourol Urodyn; 2004; 23(1):54-7. PubMed ID: 14694458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does urodynamic verification of overactive bladder determine treatment success? Results from a randomized placebo-controlled study.
    Malone-Lee JG; Al-Buheissi S
    BJU Int; 2009 Apr; 103(7):931-7. PubMed ID: 19281469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of urodynamic and detrusor contractility variables in patients with overactive bladder syndrome treated with botulinum toxin-A: is incomplete bladder emptying predictable?
    Sahai A; Sangster P; Kalsi V; Khan MS; Fowler CJ; Dasgupta P
    BJU Int; 2009 Mar; 103(5):630-4. PubMed ID: 18990156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urodynamic parameters after solifenacin treatment in men with overactive bladder symptoms and detrusor underactivity.
    Ronchi P; Gravina GL; Galatioto GP; Costa AM; Martella O; Vicentini C
    Neurourol Urodyn; 2009; 28(1):52-7. PubMed ID: 18671288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duloxetine compared with placebo for treating women with symptoms of overactive bladder.
    Steers WD; Herschorn S; Kreder KJ; Moore K; Strohbehn K; Yalcin I; Bump RC;
    BJU Int; 2007 Aug; 100(2):337-45. PubMed ID: 17511767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urodynamic effects of volume-adjustable balloons for treatment of postprostatectomy urinary incontinence.
    Utomo E; Groen J; Vroom IH; van Mastrigt R; Blok BF
    Urology; 2013 Jun; 81(6):1308-14. PubMed ID: 23465144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conventional and ambulatory urodynamic findings in women with symptoms suggestive of bladder overactivity.
    Radley SC; Rosario DJ; Chapple CR; Farkas AG
    J Urol; 2001 Dec; 166(6):2253-8. PubMed ID: 11696746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cizolirtine citrate is safe and effective for treating urinary incontinence secondary to overactive bladder: a phase 2 proof-of-concept study.
    Zát'ura F; Vsetica J; Abadías M; Pavlík I; Schraml P; Brod'ák M; Villoria J; Sust M;
    Eur Urol; 2010 Jan; 57(1):145-52. PubMed ID: 19446951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of voluntary dose escalation in a placebo-controlled, flexible-dose trial of fesoterodine in subjects with overactive bladder.
    Staskin D; Khullar V; Michel MC; Morrow JD; Sun F; Guan Z; Dmochowski R
    Neurourol Urodyn; 2011 Nov; 30(8):1480-5. PubMed ID: 21560158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.